Clinical Trial Update: Clonidine for Neurocognitive Sequelae [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial investigating clonidine for neurocognitive sequelae associated with cancer treatment has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Clonidine (clonidine)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Treatment-Related Cancer | Phase 1, Phase 2 | Status: WITHDRAWN